cookie
Translate
Visualizzazione post con etichetta medical cannabis. Mostra tutti i post
Visualizzazione post con etichetta medical cannabis. Mostra tutti i post
giovedì 7 novembre 2019
sabato 4 novembre 2017
sabato 21 ottobre 2017
giovedì 27 luglio 2017
giovedì 18 maggio 2017
How a U.S. Marijuana Company Helped Legalize MMJ in Mexico
JON HILTZ ON
There are many people and companies who stand to benefit from the upcoming legalization of medical marijuana in Mexico. First and foremost, the benefactors will be patients who need cannabis treatment now.
Coming a close second are companies in the MMJ space who stand to make incredible gains from medical legalization, and right now, there is only one company in Mexico poised for a huge win. That corporation is the American firm Medical Marijuana Inc.
Medical Marijuana Inc. is the first publicly traded cannabis company in America. The corporation also started HempMeds Mexico, their distribution arm for CBD products in the Latin nation. They were the first and are currently the only legal supplier of cannabis-based products in Mexico.
Marijuana.com sat down with CEO Dr. Stuart Titus to discuss the future of cannabis in Mexico and the role his company will be playing.
It must be incredible to see marijuana traded as a public commodity, with you and I having grown up in the era of prohibition.
It’s been absolutely amazing. It’s been exciting to see the growth here in the U.S. but also some of the Canadian licensed producers and the companies raising tremendous amounts of capital.
As of April 28th, Mexico is one signature away from having legal medical cannabis, is that still the case?
That’s still the case as best we understand. Quite exciting. Obviously, President Peña Nieto has changed his opinion on cannabis-based products. I think, in large part, this is due to one of the families that we’ve been able to assist over the last year and a half.
This gentleman, Raul Elizalde, whose daughter Grace went from having these terrible epileptic seizures to now becoming virtually seizure-free. Raul has been a very forward spokesperson. President Peña Nieto has seen how well our products have been received in Mexico since February of 2016.
Your company has been a catalyst for helping the medical marijuana industry move forward in Mexico. Can you outline how that is the case?
We had been servicing a number of families in Brazil, and of course, there are epilepsy children in Mexico whose families saw the great success in Brazil. [So they] petitioned the government to allow the products in Mexico.
The Mexican Government was very pro-CBD, but because of their unfortunate war on drugs and cartel violence, they were very anti-THC. Our products that we ship to Brazil have a trace of THC, 0.3 or less, but even trace amounts the government of Mexico was very cautious about. They challenged us to develop a fully THC-free version.
So we went to our laboratory facilities in the fall of 2015 and developed this fully THC-free version.
So this was the first-ever CBD oil allowed in Mexico?
Yes, this was the first. It was allowed February 1st, 2016. We are still the only legal cannabis-based product within Mexico today.
It’s fair to say that Medical Marijuana Inc. is poised to benefit greatly with this legalization news in Mexico.
We’re very excited about it because to date we have only been able to bring our [one product,] the THC-free version, into Mexico.
Have you spoken with the President or anyone in the Mexican government about moving forward?
Our President of Mexico Operations has spoken with President Peña Nieto. We’ve talked about moving forward in terms of education for doctors. Coming up towards the end of June I’ll be lecturing in front of about 150 doctors to help them get more familiar with not only CBD but medical cannabis.
More often than not, large corporations are dismissed for having a sole interest in their bottom line. But when speaking to Dr. Titus, you can hear the enthusiasm and passion he holds for his products, which help thousands of patients in desperate need.
Mexico is on the precipice of a whole new dimension of medicine which will help countless lives. It’s clear that the importance of this fact has not been lost on the individuals behind Medical Marijuana Inc.
Photo courtesy of Allie Beckett
martedì 9 maggio 2017
lunedì 17 aprile 2017
venerdì 10 marzo 2017
martedì 21 febbraio 2017
Ministers endorse bill to export medicinal cannabis
Ministers on Sunday endorse a draft bill to legalize export of cannabis for approved medical use, Justice Minister Ayelet Shaked’s office says, without elaborating.
Adoption by the Ministerial Committee on Legislation, which meets outside the full cabinet, means that the draft will now move forward as a government bill.
Shaked’s office says a scheduled debate on decriminalizing marijuana use in favor of fines and treatment was put back until next Sunday.
Although the recreational use of cannabis is currently illegal in the Jewish state, for the past 10 years its therapeutic use has not only been permitted but encouraged.
In 2015, doctors prescribed the herb to about 25,000 patients suffering from cancer, epilepsy, post-traumatic stress and degenerative diseases.
Last month, Public Security Minister Gilad Erdan announced his support for decriminalizing recreational use.
Shaked has reportedly indicated she will support it.
Ministers endorse bill to export medicinal cannabis
Adoption by the Ministerial Committee on Legislation, which meets outside the full cabinet, means that the draft will now move forward as a government bill.
Shaked’s office says a scheduled debate on decriminalizing marijuana use in favor of fines and treatment was put back until next Sunday.
Although the recreational use of cannabis is currently illegal in the Jewish state, for the past 10 years its therapeutic use has not only been permitted but encouraged.
In 2015, doctors prescribed the herb to about 25,000 patients suffering from cancer, epilepsy, post-traumatic stress and degenerative diseases.
Last month, Public Security Minister Gilad Erdan announced his support for decriminalizing recreational use.
Shaked has reportedly indicated she will support it.
Ministers endorse bill to export medicinal cannabis
martedì 13 dicembre 2016
Cannabis Science Inc (OTCMKTS:CBIS) Takes A Step Forward
The expert view
Dr. Ngwa said that they were pleasantly surprised with the clearly targeted missions, direct plan of action and knowledge depth offered by Cannabis Science. They discussed the drug development success and advancement the company had made so far. Partnerships between renowned scientists and CBIS team at the DF/HCC are anticipated to bring in-depth knowledge of the potential effectiveness of cannabinoids in the cancer treatment and also other chronic diseases. Dr. Ngwa added that they will outline the motivations for research partnership with a viewpoint of successfully publishing details in a renowned peer-reviewed medical journal.
Mr. Dabney participated in the talks, and together with Melvin F. Foote and Dr. Allen A. Herman, the CMO of Cannabis Science delivered a comprehensive overview of the firm and its “Cannabis Science Research” Foundation. It covered details on cannabinoids treatment, targeting different critical ailments and validating the ability to destroy cancer cells and improve the therapeutic management of different types of cancers. It engaged the Harvard faculty members in deliberating approaches to establishing a research and drug development alliance between Dana Farber/Harvard Cancer Center and Cannabis Science.
Dr. Herman commented that during the roundtable talks, they received an opportunity to discuss prospective pre-clinical, and clinical research plans and objectives with the DF/HCC scientists. The drug advancement targeting will be implemented by the new association and is projected to alter the dynamics of phyto-pharmaceutical progression, particularly in the segments of clinical study design and program implementations.
Raymond C. Dabney, the CEO and President of Cannabis Science, said that with the support of renowned team of scientists of a prestigious cancer research institution, the company hopes to launch new therapies from research to FDA nod much more quickly. The partnership strength is underscored by an in-depth knowledge of the acceptance procedures at the Food and Drug Administration.
Etichette:
business,
cannabis,
cannabis science,
CBD,
Harvard,
medical cannabis,
R&D,
thc
sabato 14 maggio 2016
venerdì 11 marzo 2016
Jimmy Carter: “Medical Marijuana Cured My Cancer”
While speaking to ABC News about the remission of his cancer, former President Jimmy Carter credited marijuana for killing of his cancer cells.
Carter told his medicinal regiment to Sawyer“I smoke two joints in the morning, I smoke two joints at night, I smoke two joint in the afternoon, and it makes me feel all right.
“Edibles are also good when traveling when smoking is not permitted.”
The future is bright for the 91-year-old humanitarian. Carter has resumed his house building for Habitat for Humanity and continues his weekly prayer service. “Marijuana is God’s medicine. I find indica is better than sativa, but there are plenty of good hybrids.“
Carter wasn’t endorsing pot smoking for everyone. “There is the right place and the right time to spark up a bowl. Don’t be a pothead but also be aware of the potential benefits of cannabis when used in moderation with the right music.
“I was never of big fan of alcohol but weed is the medicine I need. It also revived my love for peanuts. Have you ever eaten a peanut… on weed?”
With legal weed available in Colorado and Washington State and several states likely to pass the legalization next November during the Presidential elections, Carter will help support the cause in California, Oregon, and Massachusetts.
“Help build a house for those that need one and peace and sex above all else. I forget, what were we talking about?”
Etichette:
Jimmy Carter,
medical cannabis,
pot,
thc
domenica 6 marzo 2016
Iowa Business Leaders Backing Bill Expanding Medical Marijuana Law
Influential Iowa business leaders are urging state legislators to pass a bill that would expand the state’s medical marijuana laws.
The Des Moines Register reports that more than 90 business leaders sent lawmakers a letter, asking them to debate and pass comprehensive medical cannabis legislation.
“Now is the time to help suffering Iowans and their families get legal access to this medicine, and we hereby call on Iowa lawmakers to debate and pass Comprehensive Medical Cannabis legislation this session,” the letter reads.
The signers span several industries, including banking, insurance, publishing and real estate.
It’s been legal for Iowa residents with epilepsy to use cannabis oil since 2014, but proponents argue that the change was useless in practice because of a separate state law that makes it illegal to manufacture or distribute it.
The proposed legislation would grant the state authority to establish two growing facilities and distribute medical cannabis oil to people who suffer from cancer, intractable epilepsy and multiple sclerosis.
State Rep. Peter Cownie, R-West Des Moines, who introduced the measure, said he brought the issue forward after hearing stories like those from West Des Moines Mayor Steve Gaer and his wife, Sally, who have a daughter with epilepsy. The Gaers have obtained cannabis oil for their daughter and say it’s made a dramatic improvement.
“For me personally, I’ll be very disappointed for this legislative session if we don’t get this bill passed into law,” Cownie said. “From people coming up to me on the street with how supportive they are, around town, around my district, I think Iowans are ready for the change.”
The bill has cleared the House Commerce Committee and is headed to the Ways and Means Committee.
Iowa Business Leaders Backing Bill Expanding Medical Marijuana Law
The Des Moines Register reports that more than 90 business leaders sent lawmakers a letter, asking them to debate and pass comprehensive medical cannabis legislation.
“Now is the time to help suffering Iowans and their families get legal access to this medicine, and we hereby call on Iowa lawmakers to debate and pass Comprehensive Medical Cannabis legislation this session,” the letter reads.
The signers span several industries, including banking, insurance, publishing and real estate.
It’s been legal for Iowa residents with epilepsy to use cannabis oil since 2014, but proponents argue that the change was useless in practice because of a separate state law that makes it illegal to manufacture or distribute it.
The proposed legislation would grant the state authority to establish two growing facilities and distribute medical cannabis oil to people who suffer from cancer, intractable epilepsy and multiple sclerosis.
State Rep. Peter Cownie, R-West Des Moines, who introduced the measure, said he brought the issue forward after hearing stories like those from West Des Moines Mayor Steve Gaer and his wife, Sally, who have a daughter with epilepsy. The Gaers have obtained cannabis oil for their daughter and say it’s made a dramatic improvement.
“For me personally, I’ll be very disappointed for this legislative session if we don’t get this bill passed into law,” Cownie said. “From people coming up to me on the street with how supportive they are, around town, around my district, I think Iowans are ready for the change.”
The bill has cleared the House Commerce Committee and is headed to the Ways and Means Committee.
Iowa Business Leaders Backing Bill Expanding Medical Marijuana Law
Etichette:
banking,
business,
cannabis,
Des Moines,
Iowa,
medical cannabis
lunedì 11 gennaio 2016
USA - Cannabis terapeutica. Apre il primo dispensario di New York
Ha aperto i battenti a New York il primo dispensario di marijuana medica. Il punto vendita, gestito dalla società' sanitaria 'Columbia Care', e' situato nei pressi di Union Square, una delle zone più' frequentate di Manhattan. Secondo quanto riferisce la stampa americana, contrariamente alle aspettative non si tratta di un posto dove vengono distribuiti spinelli, bensi' e' una vera e propria farmacia, nonché' studio medico, dove i pazienti terminali o affetti da malattie debilitanti avranno accesso a prodotti a base di marijuana, sotto forma sia liquida, che in pillole o vaporizzata. Tutti i pazienti inoltre dovranno essere regolarmente registrati e forniti dell'autorizzazione di un medico. Secondo Nicholas Vita, presidente di 'Columbia Care, prima di aver accesso ai prodotti, i pazienti vengono prima visitati per una ventina di minuti poi potranno acquistare quanto viene ritenuto necessario. Il costo delle bottiglie di marijuana liquida varia tra i cento e i 300 dollari.
"Le persone - ha spiegato Vita - saranno messe in condizioni di capire che questo posto e' come casa loro. Non avranno nulla da vergognarsi, anzi dovranno sentirsi orgogliosi di far parte di una opportunità' pionieristica che cambierà il modo di come funzionano le cure mediche".
USA - Cannabis terapeutica. Apre il primo dispensario di New York
USA - Cannabis terapeutica. Apre il primo dispensario di New York
martedì 24 novembre 2015
lunedì 23 novembre 2015
Senator Harry Reid Signs On To Marijuana Banking Bill
| Harry Reid |
Senate Democratic Leader Harry Reid (D-NV) today signed on as a co-sponsor to the Marijuana Businesses Access to Banking Act of 2015 (S.1726), bipartisan legislation originally introduced by Sen. Jeff Merkley (D-OR), which would give state-compliant cannabis businesses access to the banking system. Sen. Reid’s support for the banking measure comes as Nevada’s medical marijuana program has begun serving patients around the state.
“Medical cannabis providers in Nevada are giving compassionate care to critically ill patients, and they shouldn’t be putting themselves in danger to do it,” said NCIA executive director Aaron Smith. “We thank Senator Reid for supporting a fix to an irrational policy that puts people at risk and forces businesses and state officials to deal with massive logistical issues.
“Ending the banking crisis would be a win for everyone from patients to regulators to small business owners, and we appreciate Senator Reid standing up for his constituents.”
S.1726 would open up banking access for state-legal cannabis businesses by protecting financial institutions against prosecution or asset forfeiture for providing services to those businesses. Sen. Reid and Sen. Merkley are joined on the bill by Senators Cory Gardner (R-CO), Michael Bennet (D-CO), Rand Paul (R-KY), Ron Wyden (D-OR), Patty Murray (D-WA), Elizabeth Warren (D-MA), and Bernie Sanders (I-VT).
Source: National Cannabis Industry Association
Senator Harry Reid Signs On To Marijuana Banking Bill
“Medical cannabis providers in Nevada are giving compassionate care to critically ill patients, and they shouldn’t be putting themselves in danger to do it,” said NCIA executive director Aaron Smith. “We thank Senator Reid for supporting a fix to an irrational policy that puts people at risk and forces businesses and state officials to deal with massive logistical issues.
“Ending the banking crisis would be a win for everyone from patients to regulators to small business owners, and we appreciate Senator Reid standing up for his constituents.”
S.1726 would open up banking access for state-legal cannabis businesses by protecting financial institutions against prosecution or asset forfeiture for providing services to those businesses. Sen. Reid and Sen. Merkley are joined on the bill by Senators Cory Gardner (R-CO), Michael Bennet (D-CO), Rand Paul (R-KY), Ron Wyden (D-OR), Patty Murray (D-WA), Elizabeth Warren (D-MA), and Bernie Sanders (I-VT).
Source: National Cannabis Industry Association
Senator Harry Reid Signs On To Marijuana Banking Bill
martedì 10 novembre 2015
Cannabis chemistry grows at the ACS
A small but growing movement to establish a division for cannabis chemists within the American Chemical Society (ACS) has scored a major victory with the establishment of a cannabis chemistry subdivision (CANN). The development comes in response to substantial recent growth in the medical and commercial cannabis industries in the US.
The new subdivision is in the chemical health and safety (CHAS) division and started life as the cannabis chemistry committee within the ACS’s small chemical business division. That committee came about as a result of a campaign that began in September 2014, when Ezra Pryor – an ACS member and president of Ezchem cannabis consultancy – started a petition to create a division.
The subdivision’s location within the CHAS should be useful because that division provides expertise in laboratory safety, chemical management and chemical safety practices. Pryor also emphasises that members of CANN will have a say in what kind of cannabis programming is presented at ACS meetings, and they will be able to voice opinions on society policy recommendations.
Since 2011, the number of cannabis testing laboratories in the US has grown from two to more than two dozen. Pryor is concerned about the current lack of knowledge on approved methods for analysing cannabis, noting that there are several sets of standardised procedures.
Cannabis chemistry grows at the ACS
Etichette:
ACS,
cannabis,
chemistry,
medical cannabis
giovedì 22 ottobre 2015
mercoledì 17 dicembre 2014
Congress Quietly Puff, Puff, Passes on the Feds’ Medical Marijuana Ban
The feds can no longer rain all over states where medical marijuana is legal, ending an era of raids on dispensaries and the patients who depend on their medicine.
Basically, a measure to end the federal government’s ban on medical MJ was included in a 1,603-page spending bill passed by Congress the weekend of December 13th. According to the new rules, which Obama will sign into law this week, the government can no longer use their funding to mess with marijuana pharmacies.
Unfortunately for the states where even recreational weed is legal, the new law won’t have an effect on nonmedical marijuana shops. Sorry, Colorado/Washington/Oregon/Alaska/Washington, D.C. Your time will come.
While Obama’s been proceeding this way for a while now, the new strategy wasn’t yet written into law. By making it official, the government’s making a permanent move away from old rules that many saw as oppressive.
Medical marijuana is currently legal in 32 states, although the DEA continues to classify it among the most dangerous narcotics, saying it has no medical use. However, cannabis has gained quite a reputation for treating kids with seizure disorders, helping cancer patients retain their appetites, and even decreasing suicide rates among young male smokers.
According to the ACLU, 52 percent of all drug arrests in 2010 had to do with marijuana — and black people are almost four times as likely as Caucasians to be arrested for pot. In other words, this new bill has the potential to save the United States a whole lot of money while ending a few seriously harmful policing practices along the way.
Could this be the beginning of the end for marijuana prohibition?
ryot.org: Congress Quietly Puff, Puff, Passes on the Feds’ Medical Marijuana Ban
Basically, a measure to end the federal government’s ban on medical MJ was included in a 1,603-page spending bill passed by Congress the weekend of December 13th. According to the new rules, which Obama will sign into law this week, the government can no longer use their funding to mess with marijuana pharmacies.
Unfortunately for the states where even recreational weed is legal, the new law won’t have an effect on nonmedical marijuana shops. Sorry, Colorado/Washington/Oregon/Alaska/Washington, D.C. Your time will come.
While Obama’s been proceeding this way for a while now, the new strategy wasn’t yet written into law. By making it official, the government’s making a permanent move away from old rules that many saw as oppressive.
Medical marijuana is currently legal in 32 states, although the DEA continues to classify it among the most dangerous narcotics, saying it has no medical use. However, cannabis has gained quite a reputation for treating kids with seizure disorders, helping cancer patients retain their appetites, and even decreasing suicide rates among young male smokers.
According to the ACLU, 52 percent of all drug arrests in 2010 had to do with marijuana — and black people are almost four times as likely as Caucasians to be arrested for pot. In other words, this new bill has the potential to save the United States a whole lot of money while ending a few seriously harmful policing practices along the way.Could this be the beginning of the end for marijuana prohibition?
ryot.org: Congress Quietly Puff, Puff, Passes on the Feds’ Medical Marijuana Ban
martedì 9 dicembre 2014
‘Designer strains’ of cannabis could cure more ills
An Israeli crop developer aims at maximizing marijuana’s medical benefits while reducing its high
BY DAVID SHAMAH December 7, 2014, 5:39 pm
| A patient purchases medicinal cannabis in Tel Aviv (photo credit: Abir Sultan/Flash90) |
Israel is one of about a dozen countries and US states that allow the use of marijuana for medical purposes, and one of the few where growing cannabis for use in medical treatment is legal. Under rules adopted last year, patients who want to use marijuana to relieve chronic pain or treat other conditions (such as psychosis) apply to one of 31 authorized doctors for a prescription, which is dispensed at authorized pharmacies.
There are eight licensed growers in Israel, one of which is a company called Seach Ltd. Seach has teamed up with an Israeli software developer called BreedIT, which has devised a technique to help breeders modify crops to emphasize specific traits. The new joint development project, formed in August, is called KanaboSeed.
The BreedIT system is based in part by research conducted by Professors Haim Rabinowitch and Nachum Kedar of Hebrew University, most famous for their work in developing popular strains of cherry tomatoes and perfecting long-life tomatoes that contain a ripening inhibitor gene to guarantee a longer shelf life.
The new technology, according to BreedIT CEO Dr. Oded Sagee, is essential to the development of the medical marijuana industry – which Sagee believes is set for a major worldwide expansion. “We decided to develop an organized breeding program to assist breeders to develop new breeds of cannabis,” Sagee said in an interview earlier this year. Currently, he said, the available strains are not optimized for medical use. “We believe that with our knowledge and background we will be able to develop new breeds that will be more effective,” he added.
Sagee, along with the other researchers working in the nascent medical marijuana business, is hoping to develop strains of cannabis that have improved CBD-to-THC ratios. THC, or tetrahydrocannabinol, is the chemical responsible for most of marijuana’s psychological effects, and is the component of cannabis that most interests casual users of cannabis; the more THC, the better the high. Those who use marijuana to relieve chronic pain also seek strains with higher levels of THC than CBD; those strains are more effective at masking pain.
CBD, or cannabidiol, has been shown in many studies to have important medical benefits, such as in the treatment of schizophrenia, depression, rheumatoid arthritis, colitis, liver inflammation, heart disease and diabetes. A good example of engineered cannabis is Avidekel, a strain developed by Israeli cannabis breeder Tikun Olam, which has a very high level of CBD and a very low level of THC. Sagee said that KanaboSeed is working with researchers to develop “designer strains” of cannabis that will contain components to treat specific medical issues, without the psychotropic effects of THC.
The applications submitted by KanaboSeed, said Sagee, “are just the first of what we anticipate will be a line of new potential cannabis varieties that KanaboSeed is developing to address specific medical uses. We intend to capitalize on the commercialization of new varieties, as allowed by the laws and regulations, in Israel and other countries where regulation permits the use of medical cannabis.”
The Agriculture Ministry and the Rural Development Plant Breeders’ Rights Council will review the applications. Hearings will be held about granting the license (no date has been set), with the public invited to give their opinions. The company will grow the new strains (on land belonging to Seach), which will be evaluated by the agencies, and once approved, the company will be granted a registration (the equivalent of a patent) for the strains.
Shay Avraham Sarid, KanaboSeed’s manager of Research and Development, said that the applications were “an important milestone for KanaboSeed. The BreedIT team contributes significant value to our development efforts, most notably the ability to streamline the breeding process. In addition to saving time, we are also developing new varieties more cost-effectively. Together we are building a product pipeline that will provide numerous opportunities for revenue growth going forward.”
Iscriviti a:
Post (Atom)
Etichette
1976
60 Minutes
ADUC droghe
ASCIA
Amendment 64
American College of Physicians
Amsterdam
Andrea Riccardi
Anno zero
Associazione Pazienti Impazienti Cannabis
Bureau of Labor Statistics
Business Insider
CNN
Center on Juvenile and Criminal Justice
Colombia
Colorado
Consiglio dei Ministri
Denver
Dimissioni Serpelloni
Initiative 502
Jeffrey Miron
OEDT
ONU
Olanda
SSN
The house I live in
Washington
antiproibizionismo
attualità
beppe grillo
businessweek
california
canapa
cannabis
cannabis ed economia
cannabis terapeutica
carceri
carta di parma
crisi economica
droga
droghe leggere
economia
fini-giovanardi
gazzetta di parma
global commission on drug policy
governo Monti
lancet
lavoce.info
legalizzazione
legalizzazione cannabis
lettere al direttore
libro
marijuana
mario monti
messico
pensieri
politica
proibizionismo
prostituzione
riflessioni
sicurezza
sole24ore
war on drugs
Archivio blog
- gennaio 2020 (1)
- dicembre 2019 (8)
- novembre 2019 (10)
- ottobre 2019 (10)
- settembre 2019 (8)
- agosto 2019 (6)
- luglio 2019 (10)
- giugno 2019 (10)
- maggio 2019 (11)
- aprile 2019 (10)
- marzo 2019 (12)
- febbraio 2019 (8)
- gennaio 2019 (9)
- dicembre 2018 (6)
- novembre 2018 (10)
- ottobre 2018 (12)
- settembre 2018 (6)
- agosto 2018 (4)
- luglio 2018 (5)
- giugno 2018 (2)
- maggio 2018 (1)
- aprile 2018 (3)
- marzo 2018 (7)
- febbraio 2018 (2)
- dicembre 2017 (1)
- novembre 2017 (5)
- ottobre 2017 (7)
- settembre 2017 (4)
- agosto 2017 (8)
- luglio 2017 (6)
- giugno 2017 (5)
- maggio 2017 (9)
- aprile 2017 (8)
- marzo 2017 (6)
- febbraio 2017 (8)
- gennaio 2017 (8)
- dicembre 2016 (4)
- novembre 2016 (5)
- ottobre 2016 (1)
- settembre 2016 (8)
- agosto 2016 (7)
- luglio 2016 (7)
- giugno 2016 (11)
- maggio 2016 (14)
- aprile 2016 (14)
- marzo 2016 (13)
- febbraio 2016 (11)
- gennaio 2016 (22)
- dicembre 2015 (17)
- novembre 2015 (29)
- ottobre 2015 (21)
- settembre 2015 (8)
- agosto 2015 (13)
- luglio 2015 (8)
- giugno 2015 (8)
- maggio 2015 (9)
- aprile 2015 (11)
- marzo 2015 (13)
- febbraio 2015 (14)
- gennaio 2015 (13)
- dicembre 2014 (10)
- novembre 2014 (1)
- ottobre 2014 (2)
- settembre 2014 (1)
- agosto 2014 (2)
- luglio 2014 (3)
- giugno 2014 (5)
- maggio 2014 (12)
- aprile 2014 (7)
- marzo 2014 (7)
- febbraio 2014 (14)
- gennaio 2014 (20)
- dicembre 2013 (9)
- novembre 2013 (2)
- ottobre 2013 (8)
- settembre 2013 (4)
- agosto 2013 (2)
- luglio 2013 (5)
- giugno 2013 (8)
- maggio 2013 (7)
- aprile 2013 (6)
- marzo 2013 (11)
- febbraio 2013 (11)
- gennaio 2013 (18)
- dicembre 2012 (23)
- novembre 2012 (24)
- ottobre 2012 (14)
- settembre 2012 (7)
- agosto 2012 (4)
- luglio 2012 (6)
- giugno 2012 (10)
- maggio 2012 (11)
- aprile 2012 (12)
- marzo 2012 (14)
- febbraio 2012 (10)
- gennaio 2012 (10)
- dicembre 2011 (112)

